Log in to save to my catalogue

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in tw...

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in tw...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31bc696495334321b45ea9a7163ec4ac

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis

About this item

Full title

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis

Publisher

New Zealand: Dove Medical Press Limited

Journal title

Journal of pain research, 2017-01, Vol.10, p.1033-1043

Language

English

Formats

Publication information

Publisher

New Zealand: Dove Medical Press Limited

More information

Scope and Contents

Contents

CR4056, (2-phenyl-6-(1H-imidazol-1yl) quinazoline), an imidazoline-2 (I2) receptor ligand, is a promising analgesic drug that has been reported to be effective in several animal models of pain. The aim of this study was to evaluate the effects of CR4056 in two well-established rat models of osteoarthritis (OA), mimicking the painful and structural...

Alternative Titles

Full title

Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_31bc696495334321b45ea9a7163ec4ac

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_31bc696495334321b45ea9a7163ec4ac

Other Identifiers

ISSN

1178-7090

E-ISSN

1178-7090

DOI

10.2147/JPR.S132026

How to access this item